Basics BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $45.27M Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 4.26% Avg Daily Range (30 D): $0.09 | 4.46% Avg Daily Range (90 D): $0.23 | 6.94% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): 6.03M Trade Size Avg Trade Size (Sh.): 138 Avg Trade Size (Sh.) (30 D): 211 Avg Trade Size (Sh.) (90 D): 198 Institutional Trades Total Inst.Trades: 908 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.87M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 4.6K     News Oct 13, 2025 @ 11:00 AM BioXcel Therapeutics to Ring Nasdaq Closing Bell o... Source: Vimal Mehta, Ph.D. Sep 18, 2025 @ 11:00 AM BioXcel Therapeutics Regains Compliance with Nasda... Source: Bioxcel Therapeutics, Inc. Aug 27, 2025 @ 12:00 PM UPDATE -- BioXcel Therapeutics Announces SERENITY ... Source: Bioxcel Therapeutics Aug 26, 2025 @ 8:00 PM BioXcel Therapeutics To Announce Topline Results f... Source: Bioxcel Therapeutics, Inc. Aug 18, 2025 @ 11:00 AM BioXcel Therapeutics Announces Positive FDA Pre-sN... Source: Bioxcel Therapeutics Financials   TTM Q3 2025 Q2 2025 Basic EPS $-9.29 $-2.18 $-2.45 Diluted EPS $-9.29 $-2.18 $-2.45 Revenue $ .75M $ .1M $ .12M Gross Profit $ -.21M $ .09M $ .01M Net Income / Loss $ -68.21M $ -30.91M $ -19.19M Operating Income / Loss $ -50.67M $ -14.23M $ -15.85M Cost of Revenue $ .96M $ .01M $ .11M Net Cash Flow $ M $ M $ M PE Ratio     Splits Feb 10, 2025:   1:16